BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:SV In extenso: from bachelor students to PhDs to professors
DTSTART:20170309T170000
DTEND:20170309T220000
DTSTAMP:20260506T051311Z
UID:04ae62e1b08ba2fd5e74e4620c218773a6a6cd82f17cda01998e5fd2
CATEGORIES:Miscellaneous
DESCRIPTION:Prof. Melanie Blokesch\n\nDr. Pamela Valdés\n\nDr. Nathalie B
 randenberg\n\nDr. Quentin Barraud\n\nProf. Denis Duboule\n\n \n\n \nThe 
 associations of SV students (AESV)\, SV PhD students (ADSV) and SV Postdoc
 s (SV Postdoc Association) are very happy to announce the first SV in ex
 tenso: from bachelor students to PhDs to professors. Everyone in SV facul
 ty plays an important role in its success- thus we organised this common e
 vent to bring the whole SV community together and celebrate our achievem
 ents! \n\nSo let’s all come together and celebrate our mutual collabora
 tion on March 9th! \nAt 5pm\, in Aud. CO3- through fascinating talk
 s\, we can explore what kind of research is going on in our faculty (see 
 details below).\nAt 7pm\, in l’Ornithorynque- we can enjoy dinner\,
  drinks and party together. For organisational purposes please fill in 
 the doodle! http://doodle.com/poll/dxcn3c2rrvv44vcf.\n-------------------
 ----------------\nList of talks and speakers:\n\nProf. Melanie Blokesch- 
 Laboratory of Molecular Microbiology\n\nBacteria are extremely abundant on
  earth and humans wouldn’t exist without them. Unfortunately\, we also f
 requently get in contact with bacterial pathogens\, which can make us sick
 . I will discuss how a process known as horizontal gene transfer fosters b
 acterial evolution in general and how it contributes to the spread of path
 ogenic traits and antibiotic resistance.\n\nDr. Pamela Valdés- Neurodegen
 erative Disease Laboratory (Aebischer Lab)\n\nModeling tau pathology using
  viral vectors for the development of novel therapeutic approaches in Alzh
 eimer’s Disease\nThe goal of our laboratory is to complement the develop
 ment of new animal models with novel therapeutic approaches in neurodegene
 rative diseases. For Alzheimer’s disease we have developed a model of ta
 u pathology in mice which allows us to evaluate the impact of tau protein 
 in neuronal function. In addition we have been able to establish a reliabl
 e model of tau propagation aiming to test different therapeutic approaches
  such as immunotherapy and anti-aggregation compounds.\n\nDr. Nathalie Bra
 ndenberg- Laboratory of Stem Cell Bioengineering (Lutolf Lab)\n\nStem cel
 ls at the base of tissue engineering 2.0\nIt is only very recently that st
 em cells were shown to have an extraordinary capacity to self-organise int
 o organ-mimicking structures when cultured in three dimensions. These “m
 ini-tissues” grown in a dish or organoids represent key functions and ca
 n give rise to differentiated cells that could not\, until now\, be cultur
 ed in conventional platforms. However\, organoids mature randomly and 
 can thus far only be obtained in relatively ill-defined and clinically irr
 elevant native ECM-derived microenvironment. We\, thus\, developed innova
 tive technologies to control and guide organoid growth and maturation usi
 ng microfluidics and hydrogel microstructuring.\n\nDr. Quentin Barraud- C
 enter for Neuroprosthetics and Brain Mind Institute (Courtine Lab)\n\nLoco
 motor prosthetics: Restoring locomotion after spinal cord injury\nWe have 
 developed a neuroprosthetic program that reestablished voluntary control o
 f paralyzed legs in rodent and primate models of spinal cord injury. The g
 oal of our laboratory is to refine this intervention with next-generation
  neurotechnologies and translate these approaches into medical devices and
  therapeutic practices for accelerating and improving functional recovery 
 after spinal cord injury in humans.\n\nProf. Denis Duboule- Laboratory of 
 Developmental Genomics
LOCATION:Aud. CO3
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR